Good GAD18 Mar 2021 19:50
Commercial Partnership with Mologic
Partnership to accelerate CE marking of Avacta's SARS-CoV-2 rapid antigen test and support COVID-19 testing in low and middle income countries
The partnership also immediately provides Avacta with additional manufacturing capacity through Mologic and its partners including Global Access Diagnostics (GAD), in addition to the scaled-up manufacturing capacity being built with BBI and Abingdon Health. Combined, these manufacturing partnerships will deliver several millions of tests per month, and potentially much higher with further investment. Avacta is also continuing its discussions with other manufacturers in the UK and overseas in order to access additional capacity to meet demand.
I feel a happy Friday coming